Skip to main content
SSO 2026 Annual Meeting Main banner

Colorectal

CME

Colorectal Great Debates

Friday, March 6, 2026
4:15 PM - 5:15 PM MST
Location:301D
CE: 1

    Moderator(s)

  • JD

    Jeremiah Deneve, DO, FACS

    Professor of Surgery
    Department of Surgery, University of North Carolina
    Chapel Hill, North Carolina, United States

  • Ramy Behman, MD, PhD

    Assistant Professor
    University of Texas MD Anderson Cancer Center
    Houston, Texas, United States

This session will address two important and debated topics in colorectal cancer surgery. First, the role of routine lateral pelvic lymph node dissection (LLND) will be discussed, focusing on its indication for rectal cancer patients with clinically suspicious lateral pelvic nodes persisting after neoadjuvant therapy, where selective LLND may reduce local recurrence and improve outcomes. Second, the session will explore the optimal extent of colectomy in patients with Lynch syndrome and localized colorectal cancer, weighing the benefits of segmental colectomy—which preserves bowel function but carries a higher risk of metachronous cancers—against extended colectomy, which reduces future cancer risk but may impact quality of life. The discussion will highlight current evidence, guideline recommendations, and the need for individualized, multidisciplinary decision-making in these complex clinical scenarios.

Learning Objectives:

  • Summarize evidence and guidelines for LPLND post-neoadjuvant therapy.
  • Identify risks, benefits, and patient selection criteria.
  • Describe recurrence risk after segmental vs. extended colectomy.
  • Apply guideline-based surgical decision-making in Lynch syndrome.

Presentations:

  • 4:18 PM - 4:32 PM MST
    Routine Lateral Pelvic Lymph Node Dissection is Indicated for Rectal Cancer Patients with Clinically Suspicious Nodes after Neoadjuvant Therapy - PRO

    Faculty: Abhineet Uppal, MD – Emory University

  • 4:32 PM - 4:45 PM MST
    Routine Lateral Pelvic Lymph Node Dissection is Indicated for Rectal Cancer Patients with Clinically Suspicious Nodes after Neoadjuvant Therapy - CON

    Faculty: Nicole Lopez, MD (she/her/hers) – UC San Diego

  • 4:45 PM - 4:59 PM MST
    The Optimal Extent of Colectomy in Patients with Lynch Syndrome and Localized Colorectal Cancer is a Segmental Colectomy - PRO

    Faculty: Mehraneh D. Jafari, MD, FACS, FASCRS – Weill Cornell Medical College

  • 4:59 PM - 5:12 PM MST
    The Optimal Extent of Colectomy in Patients with Lynch Syndrome and Localized Colorectal Cancer is a Segmental Colectomy - CON

    Faculty: Prakash K. Pandalai, MD (he/him/his) – University of Kentucky